@cardiacinterv

Stay current: Follow Cardiac Interventions Today on Twitter @cardiacinterv

News

 

FDA Accepts Protocol for Phase III Clinical Trial of Biocardia’s CardiAMP Therapy

November 11, 2014­ -- BioCardia, Inc. announced that the US Food and Drug Administration (FDA) has accepted the company’s application to begin a phase III clinical t…

Bracco Diagnostics Launches Isovue Imaging Bulk Package for CT Suite

November 24, 2014 -- Bracco Diagnostics Inc., the United States subsidiary of Bracco Imaging SpA, announced the availability of its Isovue (iopamidol injection) imaging bulk p…

EVOLVE II Data Presented for Boston Scientific’s Synergy Bioabsorbable Polymer Stent

November 19, 2014 -- Boston Scientific Corporation announced that principal investigator Dean Kereiakes, MD, presented results from the EVOLVE II trial in a late-breaking clin…

PROTECT AF Data Published for Boston Scientific’s Watchman LAA Closure Device

November 19, 2014 -- Follow-up data at approximately 4 years from the PROTECT AF trial were published by Vivek Y. Reddy, MD, et al in JAMA: Journal of the American Heart Assoc…

First-in-Man Studies Completed for Essential Medical’s 18-F Manta Large-Bore Vascular Closure Device

November 17, 2014 -- Essential Medical, Inc. announced that it has completed first-in-man studies for the Manta large-bore vascular closure device, which is designed to seal 1…

SCAI Responds to DAPT Study on Extending Therapy

November 16, 2014 -- The Society for Cardiovascular Angiography and Interventions (SCAI) issued a statement responding to the DAPT Study presented at the annual American Heart…

DAPT Study Supports Safety and Effectiveness of Extended Therapy After Stent Implantation

November 16, 2014 -- The Harvard Clinical Research Institute (HCRI) announced the results of the DAPT study, a major international study that investigated the duration of dual…

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

CTOs

 

2014 Buyer’s Guide

 

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.

Website Design by Sides Media